抗体療法及び血液抗体療法の世界市場 2020年

• 英文タイトル：Global Antibody Therapeutics and Blood Antibody Therapeutics Market 2020 by Company, Regions, Type and Application, Forecast to 2025

• レポートコード：GIR201113560 • 出版社/出版日：GlobalInfoResearch / 2020年10月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、100ページ • 納品方法：Eメール • 産業分類：医療

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本書では、抗体療法及び血液抗体療法の世界市場を調査対象にし、抗体療法及び血液抗体療法の市場概要、企業情報、企業別売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（IgG1、IgG4、その他）、用途別分析（自己免疫、腫瘍、その他）、市場予測（2021年～2025年）情報などを整理しました。 ・市場概要 ・企業情報：Roche、Takeda、Bristol-Myers Squibb、Abbvie、Alexion Pharmaceuticals、Johnson & Johnson、Biogen、Merck、Novartis、Amgen、UCB、Eli Lilly and Company、AstraZeneca ・企業別売上、市場シェア ・抗体療法及び血液抗体療法の地域別市場分析 ・抗体療法及び血液抗体療法の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・抗体療法及び血液抗体療法のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・抗体療法及び血液抗体療法のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・抗体療法及び血液抗体療法の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・抗体療法及び血液抗体療法の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・抗体療法及び血液抗体療法の種類別市場規模2015-2020：IgG1、IgG4、その他 ・抗体療法及び血液抗体療法の用途別市場規模2015-2020：自己免疫、腫瘍、その他 ・抗体療法及び血液抗体療法の世界市場予測2021-2025：地域別、種類別、用途別 ・調査の結果・結論

Market Overview
The Antibody Therapeutics and Blood Antibody Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

The most likely (base case) scenario is that the global Antibody Therapeutics and Blood Antibody Therapeutics sales will be xx in 2020 from Antibody Therapeutics and Blood Antibody Therapeutics million in 2019, with a change xx% between 2019 and 2020. In addition, based on the latest study, it is to predict that the Covid-19 will be under control in key countries like the United States, Western Europe, East Asia, by the end of Q2 (June), and will resume normal production in Q3 and Q4, the global Antibody Therapeutics and Blood Antibody Therapeutics market size is expected to grow at xx% or more annually for the next five years.

This report also researches and evaluates the impact of Covid-19 outbreak on the Antibody Therapeutics and Blood Antibody Therapeutics industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Antibody Therapeutics and Blood Antibody Therapeutics and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).

Market segmentation
Antibody Therapeutics and Blood Antibody Therapeutics market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Antibody Therapeutics and Blood Antibody Therapeutics market has been segmented into:
IgG1
IgG4
Others

By Application, Antibody Therapeutics and Blood Antibody Therapeutics has been segmented into:
Autoimmune
Tumor
Others

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Antibody Therapeutics and Blood Antibody Therapeutics market presented in the report. This section sheds light on the sales growth of different regional and country-level Antibody Therapeutics and Blood Antibody Therapeutics markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Antibody Therapeutics and Blood Antibody Therapeutics market.

The report offers in-depth assessment of the growth and other aspects of the Antibody Therapeutics and Blood Antibody Therapeutics market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Antibody Therapeutics and Blood Antibody Therapeutics Market Share Analysis
Antibody Therapeutics and Blood Antibody Therapeutics competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Antibody Therapeutics and Blood Antibody Therapeutics sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Antibody Therapeutics and Blood Antibody Therapeutics sales, revenue and market share for each player covered in this report.

The major players covered in Antibody Therapeutics and Blood Antibody Therapeutics are:
Roche
Takeda
Bristol-Myers Squibb
Abbvie
Alexion Pharmaceuticals
Johnson & Johnson
Biogen
Merck
Novartis
Amgen
UCB
Eli Lilly and Company
AstraZeneca

レポート目次

---

1 Antibody Therapeutics and Blood Antibody Therapeutics Market Overview
1.1 Product Overview and Scope of Antibody Therapeutics and Blood Antibody Therapeutics
1.2 Classification of Antibody Therapeutics and Blood Antibody Therapeutics by Type
1.2.1 Global Antibody Therapeutics and Blood Antibody Therapeutics Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Antibody Therapeutics and Blood Antibody Therapeutics Revenue Market Share by Type in 2019
1.2.3 IgG1
1.2.4 IgG4
1.2.5 Others
1.3 Global Antibody Therapeutics and Blood Antibody Therapeutics Market by Application
1.3.1 Overview: Global Antibody Therapeutics and Blood Antibody Therapeutics Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Autoimmune
1.3.3 Tumor
1.3.4 Others
1.4 Global Antibody Therapeutics and Blood Antibody Therapeutics Market by Regions
1.4.1 Global Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Antibody Therapeutics and Blood Antibody Therapeutics (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Antibody Therapeutics and Blood Antibody Therapeutics Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Antibody Therapeutics and Blood Antibody Therapeutics Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Antibody Therapeutics and Blood Antibody Therapeutics Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Antibody Therapeutics and Blood Antibody Therapeutics Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Antibody Therapeutics and Blood Antibody Therapeutics Status and Prospect (2015-2025)
1.5 COVID-19 Outbreak: Antibody Therapeutics and Blood Antibody Therapeutics Industry Impact
1.5.1 COVID-19 Potential Implications for the Antibody Therapeutics and Blood Antibody Therapeutics
1.5.1.1 Scenario One: Very Optimistic: COVID-19 has No Influence on Antibody Therapeutics and Blood Antibody Therapeutics
1.5.1.2 Scenario Two: Optimistic: COVID-19 Will Be Under Control by the End of April
1.5.1.3 Scenario Three: Gloomy: COVID-19 Will Be Under Control Between Q3 and Q4
1.5.1.4 Scenario Four: Most Likely: COVID-19 Will Be Under Control by the End of Q2
1.5.2 Opportunity Analysis in Covid-19 Crisis
1.5.3 Market Risk and Restraints
1.5.4 Market Driving Force
2 Company Profiles
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Roche SWOT Analysis
2.1.4 Roche Product and Services
2.1.5 Roche Antibody Therapeutics and Blood Antibody Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.2 Takeda
2.2.1 Takeda Details
2.2.2 Takeda Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Takeda SWOT Analysis
2.2.4 Takeda Product and Services
2.2.5 Takeda Antibody Therapeutics and Blood Antibody Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.3 Bristol-Myers Squibb
2.3.1 Bristol-Myers Squibb Details
2.3.2 Bristol-Myers Squibb Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Bristol-Myers Squibb SWOT Analysis
2.3.4 Bristol-Myers Squibb Product and Services
2.3.5 Bristol-Myers Squibb Antibody Therapeutics and Blood Antibody Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.4 Abbvie
2.4.1 Abbvie Details
2.4.2 Abbvie Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Abbvie SWOT Analysis
2.4.4 Abbvie Product and Services
2.4.5 Abbvie Antibody Therapeutics and Blood Antibody Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.5 Alexion Pharmaceuticals
2.5.1 Alexion Pharmaceuticals Details
2.5.2 Alexion Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Alexion Pharmaceuticals SWOT Analysis
2.5.4 Alexion Pharmaceuticals Product and Services
2.5.5 Alexion Pharmaceuticals Antibody Therapeutics and Blood Antibody Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.6 Johnson & Johnson
2.6.1 Johnson & Johnson Details
2.6.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Johnson & Johnson SWOT Analysis
2.6.4 Johnson & Johnson Product and Services
2.6.5 Johnson & Johnson Antibody Therapeutics and Blood Antibody Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.7 Biogen
2.7.1 Biogen Details
2.7.2 Biogen Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Biogen SWOT Analysis
2.7.4 Biogen Product and Services
2.7.5 Biogen Antibody Therapeutics and Blood Antibody Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.8 Merck
2.8.1 Merck Details
2.8.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Merck SWOT Analysis
2.8.4 Merck Product and Services
2.8.5 Merck Antibody Therapeutics and Blood Antibody Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.9 Novartis
2.9.1 Novartis Details
2.9.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Novartis SWOT Analysis
2.9.4 Novartis Product and Services
2.9.5 Novartis Antibody Therapeutics and Blood Antibody Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.10 Amgen
2.10.1 Amgen Details
2.10.2 Amgen Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Amgen SWOT Analysis
2.10.4 Amgen Product and Services
2.10.5 Amgen Antibody Therapeutics and Blood Antibody Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.11 UCB
2.11.1 UCB Details
2.11.2 UCB Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 UCB SWOT Analysis
2.11.4 UCB Product and Services
2.11.5 UCB Antibody Therapeutics and Blood Antibody Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.12 Eli Lilly and Company
2.12.1 Eli Lilly and Company Details
2.12.2 Eli Lilly and Company Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Eli Lilly and Company SWOT Analysis
2.12.4 Eli Lilly and Company Product and Services
2.12.5 Eli Lilly and Company Antibody Therapeutics and Blood Antibody Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.13 AstraZeneca
2.13.1 AstraZeneca Details
2.13.2 AstraZeneca Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 AstraZeneca SWOT Analysis
2.13.4 AstraZeneca Product and Services
2.13.5 AstraZeneca Antibody Therapeutics and Blood Antibody Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Antibody Therapeutics and Blood Antibody Therapeutics Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Antibody Therapeutics and Blood Antibody Therapeutics Players Market Share
3.2.2 Top 10 Antibody Therapeutics and Blood Antibody Therapeutics Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Antibody Therapeutics and Blood Antibody Therapeutics Revenue and Market Share by Regions
4.2 North America Antibody Therapeutics and Blood Antibody Therapeutics Revenue and Growth Rate (2015-2020)
4.3 Europe Antibody Therapeutics and Blood Antibody Therapeutics Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Antibody Therapeutics and Blood Antibody Therapeutics Revenue and Growth Rate (2015-2020)
4.5 South America Antibody Therapeutics and Blood Antibody Therapeutics Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Antibody Therapeutics and Blood Antibody Therapeutics Revenue and Growth Rate (2015-2020)
5 North America Antibody Therapeutics and Blood Antibody Therapeutics Revenue by Countries
5.1 North America Antibody Therapeutics and Blood Antibody Therapeutics Revenue by Countries (2015-2020)
5.2 USA Antibody Therapeutics and Blood Antibody Therapeutics Revenue and Growth Rate (2015-2020)
5.3 Canada Antibody Therapeutics and Blood Antibody Therapeutics Revenue and Growth Rate (2015-2020)
5.4 Mexico Antibody Therapeutics and Blood Antibody Therapeutics Revenue and Growth Rate (2015-2020)
6 Europe Antibody Therapeutics and Blood Antibody Therapeutics Revenue by Countries
6.1 Europe Antibody Therapeutics and Blood Antibody Therapeutics Revenue by Countries (2015-2020)
6.2 Germany Antibody Therapeutics and Blood Antibody Therapeutics Revenue and Growth Rate (2015-2020)
6.3 UK Antibody Therapeutics and Blood Antibody Therapeutics Revenue and Growth Rate (2015-2020)
6.4 France Antibody Therapeutics and Blood Antibody Therapeutics Revenue and Growth Rate (2015-2020)
6.5 Russia Antibody Therapeutics and Blood Antibody Therapeutics Revenue and Growth Rate (2015-2020)
6.6 Italy Antibody Therapeutics and Blood Antibody Therapeutics Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Antibody Therapeutics and Blood Antibody Therapeutics Revenue by Countries
7.1 Asia-Pacific Antibody Therapeutics and Blood Antibody Therapeutics Revenue by Countries (2015-2020)
7.2 China Antibody Therapeutics and Blood Antibody Therapeutics Revenue and Growth Rate (2015-2020)
7.3 Japan Antibody Therapeutics and Blood Antibody Therapeutics Revenue and Growth Rate (2015-2020)
7.4 Korea Antibody Therapeutics and Blood Antibody Therapeutics Revenue and Growth Rate (2015-2020)
7.5 India Antibody Therapeutics and Blood Antibody Therapeutics Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Antibody Therapeutics and Blood Antibody Therapeutics Revenue and Growth Rate (2015-2020)
8 South America Antibody Therapeutics and Blood Antibody Therapeutics Revenue by Countries
8.1 South America Antibody Therapeutics and Blood Antibody Therapeutics Revenue by Countries (2015-2020)
8.2 Brazil Antibody Therapeutics and Blood Antibody Therapeutics Revenue and Growth Rate (2015-2020)
8.3 Argentina Antibody Therapeutics and Blood Antibody Therapeutics Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Antibody Therapeutics and Blood Antibody Therapeutics by Countries
9.1 Middle East & Africa Antibody Therapeutics and Blood Antibody Therapeutics Revenue by Countries (2015-2020)
9.2 Saudi Arabia Antibody Therapeutics and Blood Antibody Therapeutics Revenue and Growth Rate (2015-2020)
9.3 UAE Antibody Therapeutics and Blood Antibody Therapeutics Revenue and Growth Rate (2015-2020)
9.4 Egypt Antibody Therapeutics and Blood Antibody Therapeutics Revenue and Growth Rate (2015-2020)
9.5 South Africa Antibody Therapeutics and Blood Antibody Therapeutics Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Antibody Therapeutics and Blood Antibody Therapeutics Revenue and Market Share by Type (2015-2020)
10.2 Global Antibody Therapeutics and Blood Antibody Therapeutics Market Forecast by Type (2019-2024)
10.3 IgG1 Revenue Growth Rate (2015-2025)
10.4 IgG4 Revenue Growth Rate (2015-2025)
10.5 Others Revenue Growth Rate (2015-2025)
11 Global Antibody Therapeutics and Blood Antibody Therapeutics Market Segment by Application
11.1 Global Antibody Therapeutics and Blood Antibody Therapeutics Revenue Market Share by Application (2015-2020)
11.2 Antibody Therapeutics and Blood Antibody Therapeutics Market Forecast by Application (2019-2024)
11.3 Autoimmune Revenue Growth (2015-2020)
11.4 Tumor Revenue Growth (2015-2020)
11.5 Others Revenue Growth (2015-2020)
12 Global Antibody Therapeutics and Blood Antibody Therapeutics Market Size Forecast (2021-2025)
12.1 Global Antibody Therapeutics and Blood Antibody Therapeutics Market Size Forecast (2021-2025)
12.2 Global Antibody Therapeutics and Blood Antibody Therapeutics Market Forecast by Regions (2021-2025)
12.3 North America Antibody Therapeutics and Blood Antibody Therapeutics Revenue Market Forecast (2021-2025)
12.4 Europe Antibody Therapeutics and Blood Antibody Therapeutics Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Antibody Therapeutics and Blood Antibody Therapeutics Revenue Market Forecast (2021-2025)
12.6 South America Antibody Therapeutics and Blood Antibody Therapeutics Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Antibody Therapeutics and Blood Antibody Therapeutics Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables
Table 1. Global Antibody Therapeutics and Blood Antibody Therapeutics Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Antibody Therapeutics and Blood Antibody Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Antibody Therapeutics and Blood Antibody Therapeutics Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Antibody Therapeutics and Blood Antibody Therapeutics Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global Antibody Therapeutics and Blood Antibody Therapeutics Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. Roche Corporate Information, Location and Competitors
Table 7. Roche Antibody Therapeutics and Blood Antibody Therapeutics Major Business
Table 8. Roche Antibody Therapeutics and Blood Antibody Therapeutics Total Revenue (USD Million) (2017-2018)
Table 9. Roche SWOT Analysis
Table 10. Roche Antibody Therapeutics and Blood Antibody Therapeutics Product and Solutions
Table 11. Roche Antibody Therapeutics and Blood Antibody Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. Takeda Corporate Information, Location and Competitors
Table 13. Takeda Antibody Therapeutics and Blood Antibody Therapeutics Major Business
Table 14. Takeda Antibody Therapeutics and Blood Antibody Therapeutics Total Revenue (USD Million) (2018-2019)
Table 15. Takeda SWOT Analysis
Table 16. Takeda Antibody Therapeutics and Blood Antibody Therapeutics Product and Solutions
Table 17. Takeda Antibody Therapeutics and Blood Antibody Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. Bristol-Myers Squibb Corporate Information, Location and Competitors
Table 19. Bristol-Myers Squibb Antibody Therapeutics and Blood Antibody Therapeutics Major Business
Table 20. Bristol-Myers Squibb Antibody Therapeutics and Blood Antibody Therapeutics Total Revenue (USD Million) (2017-2018)
Table 21. Bristol-Myers Squibb SWOT Analysis
Table 22. Bristol-Myers Squibb Antibody Therapeutics and Blood Antibody Therapeutics Product and Solutions
Table 23. Bristol-Myers Squibb Antibody Therapeutics and Blood Antibody Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. Abbvie Corporate Information, Location and Competitors
Table 25. Abbvie Antibody Therapeutics and Blood Antibody Therapeutics Major Business
Table 26. Abbvie Antibody Therapeutics and Blood Antibody Therapeutics Total Revenue (USD Million) (2017-2018)
Table 27. Abbvie SWOT Analysis
Table 28. Abbvie Antibody Therapeutics and Blood Antibody Therapeutics Product and Solutions
Table 29. Abbvie Antibody Therapeutics and Blood Antibody Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. Alexion Pharmaceuticals Corporate Information, Location and Competitors
Table 31. Alexion Pharmaceuticals Antibody Therapeutics and Blood Antibody Therapeutics Major Business
Table 32. Alexion Pharmaceuticals Antibody Therapeutics and Blood Antibody Therapeutics Total Revenue (USD Million) (2017-2018)
Table 33. Alexion Pharmaceuticals SWOT Analysis
Table 34. Alexion Pharmaceuticals Antibody Therapeutics and Blood Antibody Therapeutics Product and Solutions
Table 35. Alexion Pharmaceuticals Antibody Therapeutics and Blood Antibody Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. Johnson & Johnson Corporate Information, Location and Competitors
Table 37. Johnson & Johnson Antibody Therapeutics and Blood Antibody Therapeutics Major Business
Table 38. Johnson & Johnson Antibody Therapeutics and Blood Antibody Therapeutics Total Revenue (USD Million) (2017-2018)
Table 39. Johnson & Johnson SWOT Analysis
Table 40. Johnson & Johnson Antibody Therapeutics and Blood Antibody Therapeutics Product and Solutions
Table 41. Johnson & Johnson Antibody Therapeutics and Blood Antibody Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. Biogen Corporate Information, Location and Competitors
Table 43. Biogen Antibody Therapeutics and Blood Antibody Therapeutics Major Business
Table 44. Biogen Antibody Therapeutics and Blood Antibody Therapeutics Total Revenue (USD Million) (2017-2018)
Table 45. Biogen SWOT Analysis
Table 46. Biogen Antibody Therapeutics and Blood Antibody Therapeutics Product and Solutions
Table 47. Biogen Antibody Therapeutics and Blood Antibody Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 48. Merck Corporate Information, Location and Competitors
Table 49. Merck Antibody Therapeutics and Blood Antibody Therapeutics Major Business
Table 50. Merck Antibody Therapeutics and Blood Antibody Therapeutics Total Revenue (USD Million) (2017-2018)
Table 51. Merck SWOT Analysis
Table 52. Merck Antibody Therapeutics and Blood Antibody Therapeutics Product and Solutions
Table 53. Merck Antibody Therapeutics and Blood Antibody Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 54. Novartis Corporate Information, Location and Competitors
Table 55. Novartis Antibody Therapeutics and Blood Antibody Therapeutics Major Business
Table 56. Novartis Antibody Therapeutics and Blood Antibody Therapeutics Total Revenue (USD Million) (2017-2018)
Table 57. Novartis SWOT Analysis
Table 58. Novartis Antibody Therapeutics and Blood Antibody Therapeutics Product and Solutions
Table 59. Novartis Antibody Therapeutics and Blood Antibody Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 60. Amgen Corporate Information, Location and Competitors
Table 61. Amgen Antibody Therapeutics and Blood Antibody Therapeutics Major Business
Table 62. Amgen Antibody Therapeutics and Blood Antibody Therapeutics Total Revenue (USD Million) (2017-2018)
Table 63. Amgen SWOT Analysis
Table 64. Amgen Antibody Therapeutics and Blood Antibody Therapeutics Product and Solutions
Table 65. Amgen Antibody Therapeutics and Blood Antibody Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 66. UCB Corporate Information, Location and Competitors
Table 67. UCB Antibody Therapeutics and Blood Antibody Therapeutics Major Business
Table 68. UCB Antibody Therapeutics and Blood Antibody Therapeutics Total Revenue (USD Million) (2017-2018)
Table 69. UCB SWOT Analysis
Table 70. UCB Antibody Therapeutics and Blood Antibody Therapeutics Product and Solutions
Table 71. UCB Antibody Therapeutics and Blood Antibody Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 72. Eli Lilly and Company Corporate Information, Location and Competitors
Table 73. Eli Lilly and Company Antibody Therapeutics and Blood Antibody Therapeutics Major Business
Table 74. Eli Lilly and Company Antibody Therapeutics and Blood Antibody Therapeutics Total Revenue (USD Million) (2017-2018)
Table 75. Eli Lilly and Company SWOT Analysis
Table 76. Eli Lilly and Company Antibody Therapeutics and Blood Antibody Therapeutics Product and Solutions
Table 77. Eli Lilly and Company Antibody Therapeutics and Blood Antibody Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 78. AstraZeneca Corporate Information, Location and Competitors
Table 79. AstraZeneca Antibody Therapeutics and Blood Antibody Therapeutics Major Business
Table 80. AstraZeneca Antibody Therapeutics and Blood Antibody Therapeutics Total Revenue (USD Million) (2017-2018)
Table 81. AstraZeneca SWOT Analysis
Table 82. AstraZeneca Antibody Therapeutics and Blood Antibody Therapeutics Product and Solutions
Table 83. AstraZeneca Antibody Therapeutics and Blood Antibody Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 84. Global Antibody Therapeutics and Blood Antibody Therapeutics Revenue (Million USD) by Players (2015-2020)
Table 85. Global Antibody Therapeutics and Blood Antibody Therapeutics Revenue Share by Players (2015-2020)
Table 86. Global Antibody Therapeutics and Blood Antibody Therapeutics Revenue (Million USD) by Regions (2015-2020)
Table 87. Global Antibody Therapeutics and Blood Antibody Therapeutics Revenue Market Share by Regions (2015-2020)
Table 88. North America Antibody Therapeutics and Blood Antibody Therapeutics Revenue by Countries (2015-2020)
Table 89. North America Antibody Therapeutics and Blood Antibody Therapeutics Revenue Market Share by Countries (2015-2020)
Table 90. Europe Antibody Therapeutics and Blood Antibody Therapeutics Revenue (Million USD) by Countries (2015-2020)
Table 91. Asia-Pacific Antibody Therapeutics and Blood Antibody Therapeutics Revenue (Million USD) by Countries (2015-2020)
Table 92. South America Antibody Therapeutics and Blood Antibody Therapeutics Revenue by Countries (2015-2020)
Table 93. South America Antibody Therapeutics and Blood Antibody Therapeutics Revenue Market Share by Countries (2015-2020)
Table 94. Middle East and Africa Antibody Therapeutics and Blood Antibody Therapeutics Revenue (Million USD) by Countries (2015-2020)
Table 95. Middle East and Africa Antibody Therapeutics and Blood Antibody Therapeutics Revenue Market Share by Countries (2015-2020)
Table 96. Global Antibody Therapeutics and Blood Antibody Therapeutics Revenue (Million USD) by Type (2015-2020)
Table 97. Global Antibody Therapeutics and Blood Antibody Therapeutics Revenue Share by Type (2015-2020)
Table 98. Global Antibody Therapeutics and Blood Antibody Therapeutics Revenue Forecast by Type (2021-2025)
Table 99. Global Antibody Therapeutics and Blood Antibody Therapeutics Revenue by Application (2015-2020)
Table 100. Global Antibody Therapeutics and Blood Antibody Therapeutics Revenue Share by Application (2015-2020)
Table 101. Global Antibody Therapeutics and Blood Antibody Therapeutics Revenue Forecast by Application (2021-2025)
Table 102. Global Antibody Therapeutics and Blood Antibody Therapeutics Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Antibody Therapeutics and Blood Antibody Therapeutics Picture
Figure 2. Global Antibody Therapeutics and Blood Antibody Therapeutics Revenue Market Share by Type in 2019
Figure 3. IgG1 Picture
Figure 4. IgG4 Picture
Figure 5. Others Picture
Figure 6. Antibody Therapeutics and Blood Antibody Therapeutics Revenue Market Share by Application in 2019
Figure 7. Autoimmune Picture
Figure 8. Tumor Picture
Figure 9. Others Picture
Figure 10. Global Antibody Therapeutics and Blood Antibody Therapeutics Revenue (USD Million) and Growth Rate (2015-2025)
Figure 11. North America Antibody Therapeutics and Blood Antibody Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Europe Antibody Therapeutics and Blood Antibody Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Asia-Pacific Antibody Therapeutics and Blood Antibody Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. South America Antibody Therapeutics and Blood Antibody Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Middle East and Africa Antibody Therapeutics and Blood Antibody Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Antibody Therapeutics and Blood Antibody Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Antibody Therapeutics and Blood Antibody Therapeutics Revenue Share by Players in 2019
Figure 18. Global Top 5 Players Antibody Therapeutics and Blood Antibody Therapeutics Revenue Market Share in 2019
Figure 19. Global Top 10 Players Antibody Therapeutics and Blood Antibody Therapeutics Revenue Market Share in 2019
Figure 20. Key Players Market Share Trend
Figure 21. Global Antibody Therapeutics and Blood Antibody Therapeutics Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 22. Global Antibody Therapeutics and Blood Antibody Therapeutics Revenue Market Share by Regions (2015-2020)
Figure 23. Global Antibody Therapeutics and Blood Antibody Therapeutics Revenue Market Share by Regions in 2018
Figure 24. North America Antibody Therapeutics and Blood Antibody Therapeutics Revenue and Growth Rate (2015-2020)
Figure 25. Europe Antibody Therapeutics and Blood Antibody Therapeutics Revenue and Growth Rate (2015-2020)
Figure 26. Asia-Pacific Antibody Therapeutics and Blood Antibody Therapeutics Revenue and Growth Rate (2015-2020)
Figure 27. South America Antibody Therapeutics and Blood Antibody Therapeutics Revenue and Growth Rate (2015-2020)
Figure 28. Middle East and Africa Antibody Therapeutics and Blood Antibody Therapeutics Revenue and Growth Rate (2015-2020)
Figure 29. North America Antibody Therapeutics and Blood Antibody Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 30. North America Antibody Therapeutics and Blood Antibody Therapeutics Revenue Market Share by Countries in 2019
Figure 31. USA Antibody Therapeutics and Blood Antibody Therapeutics Revenue and Growth Rate (2015-2020)
Figure 32. Canada Antibody Therapeutics and Blood Antibody Therapeutics Revenue and Growth Rate (2015-2020)
Figure 33. Mexico Antibody Therapeutics and Blood Antibody Therapeutics Revenue and Growth Rate (2015-2020)
Figure 34. Europe Antibody Therapeutics and Blood Antibody Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 35. Europe Antibody Therapeutics and Blood Antibody Therapeutics Revenue Market Share by Countries in 2019
Figure 36. Germany Antibody Therapeutics and Blood Antibody Therapeutics Revenue and Growth Rate (2015-2020)
Figure 37. UK Antibody Therapeutics and Blood Antibody Therapeutics Revenue and Growth Rate (2015-2020)
Figure 38. France Antibody Therapeutics and Blood Antibody Therapeutics Revenue and Growth Rate (2015-2020)
Figure 39. Russia Antibody Therapeutics and Blood Antibody Therapeutics Revenue and Growth Rate (2015-2020)
Figure 40. Italy Antibody Therapeutics and Blood Antibody Therapeutics Revenue and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Antibody Therapeutics and Blood Antibody Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 42. Asia-Pacific Antibody Therapeutics and Blood Antibody Therapeutics Revenue Market Share by Countries in 2019
Figure 43. China Antibody Therapeutics and Blood Antibody Therapeutics Revenue and Growth Rate (2015-2020)
Figure 44. Japan Antibody Therapeutics and Blood Antibody Therapeutics Revenue and Growth Rate (2015-2020)
Figure 45. Korea Antibody Therapeutics and Blood Antibody Therapeutics Revenue and Growth Rate (2015-2020)
Figure 46. India Antibody Therapeutics and Blood Antibody Therapeutics Revenue and Growth Rate (2015-2020)
Figure 47. Southeast Asia Antibody Therapeutics and Blood Antibody Therapeutics Revenue and Growth Rate (2015-2020)
Figure 48. South America Antibody Therapeutics and Blood Antibody Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 49. South America Antibody Therapeutics and Blood Antibody Therapeutics Revenue Market Share by Countries in 2019
Figure 50. Brazil Antibody Therapeutics and Blood Antibody Therapeutics Revenue and Growth Rate (2015-2020)
Figure 51. Argentina Antibody Therapeutics and Blood Antibody Therapeutics Revenue and Growth Rate (2015-2020)
Figure 52. Middle East and Africa Antibody Therapeutics and Blood Antibody Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 53. Middle East and Africa Antibody Therapeutics and Blood Antibody Therapeutics Revenue Market Share by Countries in 2019
Figure 54. Saudi Arabia Antibody Therapeutics and Blood Antibody Therapeutics Revenue and Growth Rate (2015-2020)
Figure 55. UAE Antibody Therapeutics and Blood Antibody Therapeutics Revenue and Growth Rate (2015-2020)
Figure 56. Egypt Antibody Therapeutics and Blood Antibody Therapeutics Revenue and Growth Rate (2015-2020)
Figure 57. South Africa Antibody Therapeutics and Blood Antibody Therapeutics Revenue and Growth Rate (2015-2020)
Figure 58. Global Antibody Therapeutics and Blood Antibody Therapeutics Revenue Share by Type (2015-2020)
Figure 59. Global Antibody Therapeutics and Blood Antibody Therapeutics Revenue Share by Type in 2019
Figure 60. Global Antibody Therapeutics and Blood Antibody Therapeutics Market Share Forecast by Type (2021-2025)
Figure 61. Global IgG1 Revenue Growth Rate (2015-2020)
Figure 62. Global IgG4 Revenue Growth Rate (2015-2020)
Figure 63. Global Others Revenue Growth Rate (2015-2020)
Figure 64. Global Antibody Therapeutics and Blood Antibody Therapeutics Revenue Share by Application (2015-2020)
Figure 65. Global Antibody Therapeutics and Blood Antibody Therapeutics Revenue Share by Application in 2019
Figure 66. Global Antibody Therapeutics and Blood Antibody Therapeutics Market Share Forecast by Application (2021-2025)
Figure 67. Global Autoimmune Revenue Growth Rate (2015-2020)
Figure 68. Global Tumor Revenue Growth Rate (2015-2020)
Figure 69. Global Others Revenue Growth Rate (2015-2020)
Figure 70. Global Antibody Therapeutics and Blood Antibody Therapeutics Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 71. Global Antibody Therapeutics and Blood Antibody Therapeutics Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 72. Global Antibody Therapeutics and Blood Antibody Therapeutics Revenue Market Share Forecast by Regions (2021-2025)
Figure 73. North America Antibody Therapeutics and Blood Antibody Therapeutics Revenue Market Forecast (2021-2025)
Figure 74. Europe Antibody Therapeutics and Blood Antibody Therapeutics Revenue Market Forecast (2021-2025)
Figure 75. Asia-Pacific Antibody Therapeutics and Blood Antibody Therapeutics Revenue Market Forecast (2021-2025)
Figure 76. South America Antibody Therapeutics and Blood Antibody Therapeutics Revenue Market Forecast (2021-2025)
Figure 77. Middle East and Africa Antibody Therapeutics and Blood Antibody Therapeutics Revenue Market Forecast (2021-2025)
Figure 78. Sales Channel: Direct Channel vs Indirect Channel

---